Prosecution Insights
Prosecution Insights
4 pending office actions • 4 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 4 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 4 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (50%) |
| §102 only | 1 (25%) |
| No statute on record | 1 (25%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ABDALHAMEED, MANAHIL MIRGHANI ALI | 1 | 50.4% | +41.3% |
| LIPPOLIS, ALEXANDRA ROSE | 1 | 36.4% | +70.1% |
| POLLOCK, ZACHARY JOSEPH | 1 | 26.1% | +59.2% |
| SULLIVAN, STEPHANIE LAUREN | 1 | 60.9% | +38.7% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17775087 | METHOD FOR MANUFACTURING A TRIDIMENSIONNAL BLOOD VESSEL | POLLOCK, ZACHARY JOSEPH | 93d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18589498 | INFIGRATINIB FOR TREATMENT OF FGFR3-RELATED SKELETAL DISEASES DURING PREGNANCY | ABDALHAMEED, MANAHIL MIRGHANI ALI | 112d overdue |
| 17775087 | METHOD FOR MANUFACTURING A TRIDIMENSIONNAL BLOOD VESSEL | POLLOCK, ZACHARY JOSEPH | 93d overdue |
| 17998603 | BASE EDITING APPROACHES FOR THE TREATMENT OF BETAHEMOGLOBINOPATHIES | LIPPOLIS, ALEXANDRA ROSE | 4d overdue |
| 17274966 | METHODS FOR INCREASING FETAL HEMOGLOBIN CONTENT IN EUKARYOTIC CELLS AND USES THEREOF FOR THE TREATMENT OF HEMOGLOBINOPATHIES | SULLIVAN, STEPHANIE LAUREN | 12d |
| Art Unit | Apps |
|---|---|
| 1622 | 1 |
| 1637 | 1 |
| 3715 | 1 |
| 1635 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18589498 | INFIGRATINIB FOR TREATMENT OF FGFR3-RELATED SKELETAL DISEASES DURING PREGNANCY | ABDALHAMEED, MANAHIL MIRGHANI ALI | 1622 | Other | Non-Final OA | 112d overdue | Pending | Feb 28, 2024 |
| 17998603 | BASE EDITING APPROACHES FOR THE TREATMENT OF BETAHEMOGLOBINOPATHIES | LIPPOLIS, ALEXANDRA ROSE | 1637 | §103 | Final Rejection | 4d overdue | Pending | Nov 11, 2022 |
| 17775087 | METHOD FOR MANUFACTURING A TRIDIMENSIONNAL BLOOD VESSEL | POLLOCK, ZACHARY JOSEPH | 3715 | §102 | Non-Final OA | 93d overdue | Pending | May 06, 2022 |
| 17274966 | METHODS FOR INCREASING FETAL HEMOGLOBIN CONTENT IN EUKARYOTIC CELLS AND USES THEREOF FOR THE TREATMENT OF HEMOGLOBINOPATHIES | SULLIVAN, STEPHANIE LAUREN | 1635 | §103 | Non-Final OA | 12d | Pending | Mar 10, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial